Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Santhera Pharmaceuticals Holding AG    SANN   CH0027148649

SANTHERA PHARMACEUTICALS HOLDING AG (SANN)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
04/17/2018 04/18/2018 04/19/2018 04/20/2018 04/23/2018 Date
18.5(c) 19.2(c) 19.78(c) 19.26(c) 19.32 Last
6 804 23 050 60 844 31 237 1 228 Volume
0.00% +3.78% +3.02% -2.63% +0.31% Change
More quotes
Financials (CHF)
Sales 2018 30,0 M
EBIT 2018 -28,0 M
Net income 2018 -25,0 M
Finance 2018 33,0 M
Yield 2018 -
Sales 2019 39,0 M
EBIT 2019 -9,00 M
Net income 2019 -9,00 M
Finance 2019 25,0 M
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales2018 3,09x
EV / Sales2019 2,58x
Capitalization 126 M
More Financials
Company
Santhera Pharmaceuticals Holding AG is a pharmaceutical company.It engages in the development, marketing, and commercialization of pharmaceutical products for the treatment of neuro-ophthalmological, neuromuscular, and pulmonary diseases.It offers its products under the Raxone brands.The company... 
Sector
Pharmaceuticals
Calendar
05/18Presentation
More about the company
Latest news on SANTHERA PHARMACEUTICALS H
04/17SANTHERA PHARMACEUTICALS : Shareholders approve all Board Proposals at Today's A..
AQ
04/12SANTHERA PHARMACEUTICALS : Shareholders Approve all Board Proposals at Today's A..
GL
04/09SANTHERA PHARMACEUTICALS : Announces Successful Completion of First Clinical Tri..
AQ
04/06SANTHERA PHARMACEUTICALS : Announces Successful Completion of First Clinical Tri..
AQ
04/05SANTHERA PHARMACEUTICALS : Announces Successful Completion of First Clinical Tri..
GL
03/23SANTHERA PHARMACEUTICALS : Reports Solid Top-line Growth in 2017 and Reiterates ..
AQ
03/20SANTHERA PHARMACEUTICALS : Reports Solid Top-line Growth in 2017 and Reiterates ..
GL
03/15SANTHERA PHARMACEUTICALS HOLDING AG : annual earnings release
03/08SANTHERA PHARMACEUTICALS : Reports Outcome of Exploratory Trial with Idebenone i..
AQ
03/06SANTHERA PHARMACEUTICALS : Reports Outcome of Exploratory Trial with Idebenone i..
AQ
More news
Sector news : Specialty & Advanced Pharmaceuticals
08:16aSHIRE PLC SHIRE PLC : Rule 2.9 Announcement
DJ
04/21TAKEDA PHARMACEUTICAL : Keeps Courting Shire -- WSJ
DJ
04/20GRAIN HIGHLIGHTS : Top Stories of the Day
DJ
04/20Japan's Takeda sweetens $62 billion Shire offer
RE
04/20SHIRE PLC SHIRE PLC : Statement Re Proposal From -2-
DJ
More sector news : Specialty & Advanced Pharmaceuticals
Latest Tweets
04/12Santhera Pharmaceuticals : Shareholders Approve all Board Proposals at Today'.. 
02/22Santhera Pharmaceuticals : Completes Capital Increase to Settle Obtained Lice.. 
01/29Santhera Pharmaceuticals : Reports Preliminary Key Financial Figures for 2017.. 
01/24Santhera Pharmaceuticals : Anticipates Receiving a Negative CHMP Opinion on A.. 
01/19Santhera Pharmaceuticals : Plans to Announce Regulatory Feedback for Raxone® .. 
More tweets
Qtime:22
News from SeekingAlpha
04/09Mereo BioPharma Proposes Terms For U.S. IPO 
03/27Mereo BioPharma Group Files For U.S. IPO 
2017Interview - Santhera Readies Muscular Dystrophy Push 
2016Duchenne Assets Soar In The Wake Of Exondys 51 Approval 
2016Recent Setbacks Have Duchenne Investors On Edge 
Chart SANTHERA PHARMACEUTICALS H
Duration : Period :
Santhera Pharmaceuticals H Technical Analysis Chart | SANN | CH0027148649 | 4-Traders
Technical analysis trends SANTHERA PHARMACEUTICALS H
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 2
Average target price 41,5  CHF
Spread / Average Target 115%
EPS Revisions
Managers
NameTitle
Thomas Meier Chief Executive Officer & Director
Elmar J. Schnee Chairman
Christoph Rentsch Chief Financial Officer
Kristina Sjöblom Nygren Chief Medical Officer, EVP & Head-Development
Martin Gertsch Vice Chairman
Sector and Competitors
1st jan.Capitalization (M$)
SANTHERA PHARMACEUTICALS HOLDING AG-46.43%129
ABBVIE-4.25%146 927
MERCK KGAA-8.61%13 024
KYOWA HAKKO KIRIN CO LTD6.80%12 707
JAZZ PHARMACEUTICALS PLC17.30%9 446
ZHANGZHOU PIENTZEHUANG PHARMACEUTICL LTD35.57%8 212